SEC Form 4 · accession 0001209191-16-129931
Cascadian Therapeutics, Inc. · CASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Dunseth Myers
Officer — President and CEO · Director
Period of report
Jun 28, 2016
Accepted (ET)
Jun 28, 2016 · 5:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412067
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 28, 2016 | P | 62,500 | $0.80 | A | 62,500 | D |
Table II — derivative securities
No Table II lines on this filing.